维普中文期刊产品整合服务
40篇 您的检索式:作者名="MILLER ANN"
    题名 作者 年代 出处 被引量
1Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma显示文摘Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and a major cause of cancer-related mortality for which liver resection is an important curative-intent treatment option. However, many patients present with advanced disease and with underlying chronic liver disease and/or cirrhosis, limiting the proportion of patients who are surgical candidates. In addition, the development of recurrent or de novo cancers following surgical resection is common. These issues have led investigators to evaluate the benefit of neoadjuvant and adjuvant treatment strategies aimed at improving resectability rates and decreasing recurrence rates. While high-level evidence to guide treatment decision making is lacking, recent advances in locoregional and systemic therapies, including antiviral treatment and immunotherapy, raise the prospect of novel approaches that may improve the outcomes of patients with HCC. In this review, we evaluate the evidence for various neoadjuvant and adjuvant therapies and discuss opportunities for future clinical and translational research.Clifford Akateh Sylvester M Black Lanla Conteh Eric D Miller Anne Noonan Eric Elliott Timothy M Pawlik Allan Tsung Jordan M Cloyd 2019World Journal of Gastroenterology2019,25,28:16
2Management and outcome of recurrent gallstone ileus:A systematic review显示文摘AIM: To help the surgeon in decision making whentreating a patient with recurrent gallstone ileus(RGSI). METHODS: A systematic review related to RGSI was performed using the databases CINAHL, EMBASE, MEDLINE via Pub Med from May 1912 to April 2015. All languages were included and the grey literature was also searched. The abstracts were explored for relevance to the topic and full texts obtained as appropriate. A manual search was carried out by scrutinising the reference lists of all the full text articles and further articles were identified and obtained. Total of 903 articles were identified, 656 were excluded after abstract review, 247 full text articles were reviewed and 91 articles selected for final analysis. There were 113 cases of RGSI. RESULTS: There were 113 cases of RGSI reported in 91 articles. The majority of the recurrences, 62.6%, occurred within 6 wk of the index event. The male to female ratio was 1:7. The mean age was 69.6 years(SD 11.2) with a range of 38-95 years. The small bowel was the commonest site of impaction(92.2%). Treatment data was available for 104 patients. The two main operations performed were:(1) Enterolithotomy without repair of biliary fistula in 70.1% of all patients with a procedural mortality rate of 16.4%(12/73) and(2) a single stage surgery approach involving enterolithotomy with cholecystectomy and repair of the biliary enteric fistula in 16.3% with a procedural mortality of 11.7%(2/17). A subset analysis over last 25 years showed mortality from eneterolithotomy was 4.8% while single stage mortality was 22.2%. Enterolithotomy alone was the commonest operation performed for RGSI with four patients(5.4%) having a further recurrence of gallstone ileus. CONCLUSION: Enterolithotomy alone or followed by a delayed two-stage treatment approach is the preferred choice offering low mortality and reduced risk of recurrence.Shovkat Ahmad Mir Zeiad Hussain Christine Ann Davey Glenn Vincent Miller Srinivas Chintapatla 2015World Journal of Gastrointestinal Surgery2015,7,8:3
3Successful treatment of intravenously abused oral Opana ER‐induced thrombotic microangiopathy without plasma exchange显示文摘Peter John Miller Andrew Matthew Farland Mary Ann Knovich Katharine Marie Batt John Owen 2014Am. J. Hematol2014,,:2
4Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus显示文摘Frank B. Pomposelli Edward J. Marcaccio Gary W. Gibbons David R. Campbell Dorothy V. Freeman Anne M. Burgess Arnold Miller Frank W. LoGerfo 1995Journal of Vascular Surgery1995,,:2
5Iris manipulation during phacoemulsification:intraoperative and postoperative complications显示文摘AIM:To quantify intraoperative and postoperative complications in complex phacoemulsification cataract extraction(phacoemulsification)with iris manipulation compared to non-complex and complex phacoemulsification without iris manipulation.METHODS:All phacoemulsification cases at the University of Colorado between January 1,2014,and June 30,2017 were included.Exclusion criteria for the primary outcome of intraoperative complications were planned combination surgery and eyes with less than 28 d followup.Exclusion criteria for the secondary outcomes of postoperative complications were unplanned additional surgery,and chronic steroid eye drop use prior to surgery.Data including sex,race/ethnicity,surgery length,visual acuity,intraoperative and postoperative complications,and intraocular pressures(IOP)were collected and analyzed utilizing general linear and Logistic regression modeling.RESULTS:The medical records of 5772 eyes were reviewed(500 complex without iris manipulation,367 with iris manipulation).The number of any intraoperative complication in the complex with iris manipulation and complex without iris manipulation groups was 15(4.1%)and 26(5.2%),respectively,compared to 41(0.8%)in the non-complex group.Postoperative inflammation was found in 135(2.8%)non-complex cases,20(4.1%)complex cases without iris manipulation,and 20(5.6%)complex cases with iris manipulation.The adjusted odds ratio of postoperative inflammation in phacoemulsification with iris manipulation compared to non-complex was 2.3(95%CI:1.3-4.0,P=0.005).The rate of IOP spikes>10 mm Hg was significantly greater in cases with iris manipulation(P=0.001).CONCLUSION:Complex cases have more intraoperative complications.However,only complex cases with iris manipulation led to increase rates of postoperative inflammation and IOP spikes>10 mm Hg.Eric R.Williams Jennifer L.Patnaik D.Claire Miller Anne M.Lynch Richard S.Davidson Malik Y.Kahook Leonard K.Seibold 2021International Journal of Ophthalmology(English edition)2021,14,5:2
6Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial显示文摘David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Takamaru Ashikaga Donald L Weaver Barbara J Miller Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Denise M Mammolito David R McCready Eleftherios P Mamo 2007Lancet Oncology2007,,10:2
7The risk assess- ment- policy gap:An example from the UK contaminated land regime显示文摘Jens Evans Graham Wood&Anne Miller 2006Environment International2006,32,:1
8Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association显示文摘Michael Miller Neil J. Stone Christie Ballantyne Vera Bittner Michael H. Criqui Henry N. Ginsberg Anne Carol Goldberg William James Howard Marc S. Jacobson Penny M. Kris-Etherton Terry A. Lennie Moshe Levi Theodore Mazzone Subramanian Pennathur 2011Circulation2011,,20:1
9The biogeochemistry and zoogeography of lakes and rivers in arctic Alaska显示文摘George W. Kling W. John O’Brien Michael C. Miller Anne E. Hershey 1992Hydrobiologia (-)1992,,1:1
10Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction显示文摘 Sharkey SW Christensen D McCoy M Miller EA Mary Ann M 1999Am Heart J1999,137,2:1
11Effect of (?)-hydroxycitrate upon the accumulation of lipid in the rat: I. Lipogenesis显示文摘Ann C. Sullivan Joseph Triscari James G. Hamilton O. Neal Miller Victor R. Wheatley 1974Lipids1974,,2:1
12The Caenorhabditis elegans hunchback -like Gene lin-57/hbl-1 Controls Developmental Time and Is Regulated by MicroRNAs显示文摘Juan E. Abrahante Aric L. Daul Ming Li Mandy L. Volk Jason M. Tennessen Eric A. Miller Ann E. Rougvie 2003Developmental Cell2003,,5:1
13Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma显示文摘Wenqing Qi Laurence S. Cooke Xiaobing Liu Lisa Rimsza Denise J. Roe Ann Manziolli. Daniel O. Persky Thomas P. Miller Daruka Mahadevan 2011Biochemical Pharmacology2011,,7:1
14Family Ties in Entrepreneurs’ Social Networks and New Venture Growth显示文摘Jean‐Luc Arregle Bat Batjargal Michael A. Hitt Justin W. Webb Toyah Miller Anne S. Tsui 2015Entrepreneurship Theory and Practice2015,,2:1
15Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction显示文摘Alireza Falahati Scott W. Sharkey Dane Christensen Matt McCoy Elizabeth A. Miller Mary Ann Murakami Fred S. Apple 1999American Heart Journal1999,,:1
16Glial toll-like receptor signaling in central nervous system infection and autoimmunity显示文摘Pamela A. Carpentier D’Anne S. Duncan Stephen D. Miller 2007Brain Behavior and Immunity2007,,2:1
17High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy显示文摘James R Headrick Francis C Nichols Daniel L Miller Mark S Allen Victor F Trastek Claude Deschamps Cathy D Schleck Ann M Thompson Peter C Pairolero 2002The Annals of Thoracic Surgery2002,,6:1
18Estimating crop stresses, aboveground dry biomass and yield of corn using multi-temporal optical data combined with a radiation use efficiency model显示文摘Jiangui Liu Elizabeth Pattey John R. Miller Heather McNairn Anne Smith Baoxin Hu 2009Remote Sensing of Environment2009,,6:1
19Effects of Recombinant Human Growth Hormone in Anorexia Nervosa: A Randomized, Placebo-Controlled Study显示文摘Pouneh K. Fazeli Elizabeth A. Lawson Rajani Prabhakaran Karen K. Miller Daniel A. Donoho David R. Clemmons David B. Herzog Madhusmita Misra Anne Klibanski 2010The Journal of Clinical Endocrinology & Metabolism2010,,11:1
20Lamotrigine in patients with epilepsy and comorbid depressive symptoms显示文摘Toufic A. Fakhoury John J. Barry J. Mitchell Miller Anne E. Hammer Alain Vuong 2006Epilepsy and Behavior2006,,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费